Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CAVA Group, Inc.(CAVA) | 9,507,990 | 9,507,990 | 0 | $558.02M | $769.20M | 76.11% | +$211.17M |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 136,180,481 | 154,734,327 | +18,553,846 | $156.61M | $241.39M | 23.89% | +$84.78M |